Patheon to Showcase API Development Capabilities at InformEx - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Patheon to Showcase API Development Capabilities at InformEx



Patheon, a provider of contract development and commercial manufacturing services, will showcase its late-stage API development capabilities at InformEx in Miami, Fla., January 21-24, 2014. In addition, many Patheon executives as well as technical and scientific professionals will also attend InformEx and will be available to discuss Patheon's API development capabilities. Patheon will be exhibiting at Booth #1010 for the duration of the conference. InformEx offers participants a direct view of what is happening globally across the fine, specialty, and custom chemical marketplace. The event brings together an international mix of buyers and sellers for four days of sourcing, education, and networking.

Source: Patheon

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here